Investigators assessed the efficacy of 10-kHz high-frequency devices as a rescue treatment in patients with failed conventional spinal cord stimulation therapy for chronic pain without needing to change the spinal hardware.
The researchers sought to evaluate the relationship between pain management and stimulant use in people with chronic pain.
Researchers developed a framework to differentiate PD- from non-PD-related pain and classify PD-related pain into 3 groups — nociceptive, neuropathic, or nociplastic.
Data analysis revealed that CGRP mAbs were discontinued more frequently than onabotulinumtoxinA (23% vs 3%).
The main goal of this study was to characterize sex differences and abnormalities in the functional segregation and integration of the whole-brain network architecture associated with chronic pain.
About 20.5% of adults reported pain on most days or every day based on a chronic pain module introduced into the 2019 edition of the NHIS.
Because current treatment options are not effective for many patients with painful diabetic neuropathy, investigators evaluated the impact of spinal cord stimulation on those with this progressive chronic pain condition.
The Guideline Development Group of the WHO agreed that its recommendations on managing chronic pain in children would be based on the principles that access to pain management is a fundamental human right and children have a right to the highest possible standard of health.
The authors of this review present key epidemiologic data about cancer patients vulnerable for each pain syndrome along with evidence for the management for each condition.
The objective of this study was to assess the efficacy and safety of N-acetylcysteine in the treatment of any chronic pain condition in adults.
